Association Between Absorbed Dose Heterogeneity and Metabolic Response in HCC Patients Undergoing Transarterial Radioembolization with Y-90 Resin Microspheres

被引：0
|
作者：
Coskun, N. [1 ]
Kartal, M. [2 ]
Erdogan, A. [2 ]
Ozdemir, E. [1 ]
机构：
[1] Ankara Yildirim Beyazit Univ, Ankara Bilkent City Hosp, Ankara, Turkiye
[2] Ankara Bilkent City Hosp, Ankara, Turkiye
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-914
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [21] Dose distribution parameters for the prescription in ICC (intrahepatic cholangiocarcinoma) patients undergoing Transarterial Radioembolization with 90Y
    Tarrats-Rosell, J.
    Cobo-Rodriguez, A.
    Ninerola-Baizan, A.
    Casanueva-Elicery, S.
    Romero-Zayas, I.
    Quintero, K.
    Fuster-Pelfort, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S809 - S810
  • [22] Dose-Response Relationship in Patients with Liver Metastases from Neuroendocrine Neoplasms Undergoing Radioembolization with 90 Y Glass Microspheres
    Watanabe, Masao
    Leyser, Stephan
    Theysohn, Jens
    Schaarschmidt, Benedikt
    Ludwig, Johannes
    Fendler, Wolfgang P.
    Moraitis, Alexandros
    Lahner, Harald
    Mathew, Annie
    Herrmann, Ken
    Weber, Manuel
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (08) : 1175 - 1180
  • [23] Impact of sarcopenia evaluated using the total psoas area (TPA) in patients undergoing Y-90 radioembolization for hepatocellular carcinoma (HCC).
    Ioannides, Pericles
    Abuodeh, Yazan
    Jin, Will
    Hoffe, Sarah E.
    Frakes, Jessica M.
    Kim, Richard D.
    Choi, Junsung
    El-Hadda, Ghassan E.
    Biebel, Benjamin
    Kis, Bela
    Sweeney, Jennifer
    Friedman, Mark
    Kothari, Nishi
    Anaya, Daniel A.
    Latifi, Kujtim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [24] The ROWAN study: Safety and efficacy of transarterial radioembolization with Y-90 glass microspheres and the STRIDE regimen in hepatocellular carcinoma.
    He, Aiwu Ruth
    Toskich, Beau
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS622 - TPS622
  • [25] Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for Y-90 resin microspheres
    Kennedy, Andrew S.
    Ball, David
    Cohen, Steven J.
    Cohn, Michael
    Coldwell, Douglas M.
    Drooz, Alain
    Ehrenwald, Eduardo
    Kanani, Samir
    Rose, Steven C.
    Nutting, Charles W.
    Moeslein, Fred M.
    Savin, Michael A.
    Schirm, Sabine
    Putnam, Samuel G., III
    Sharma, Navesh K.
    Wang, Eric A.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (02) : 134 - +
  • [26] A comparison of techniques for Y-90 PET/CT image-based dosimetry following radioembolization with resin microspheres
    Pasciak, Alexander S.
    Bourgeois, Austin C.
    Bradley, Yong C.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [27] European multicenter evaluation of survival for patients with hepatocellular carcinoma (HCC) treated by radioembolization with 90y-labeled resin microspheres
    Sangro, B.
    Carpanese, L.
    Cianni, R.
    Golfieri, R.
    Gasparini, D.
    Ezzidin, S.
    Hoffman, R.
    Fiore, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison
    Agirrezabal, Ion
    Bouattour, Mohamed
    Pinato, David J.
    D'Alessio, Antonio
    Brennan, Victoria K.
    Carion, Phuong Lien
    Shergill, Suki
    Amoury, Nathalie
    Vilgrain, Valerie
    EUROPEAN JOURNAL OF CANCER, 2024, 196
  • [29] RADIOEMBOLIZATION WITH Y-90 GLASS MICROSPHERES IN ADVANCED HEPATOCELLULAR CARCINOMA: SAFETY, RESPONSE AND SURVIVAL IN A EUROPEAN COHORT OF 108 PATIENTS
    Hilgard, Philip
    Antoch, Gerald
    El Fouly, Amr H.
    Hamami, Monia
    Scherag, Andre
    Ertle, Judith M.
    Paul, Andreas
    Bockisch, Andreas
    Gerken, Guido
    HEPATOLOGY, 2009, 50 (04) : 1082A - 1082A
  • [30] Clinical Outcomes Of Patients With Primary Or Metastatic Liver Tumors Treated With Dose-Escalated Yttrium-90 (Y-90) Transarterial Radioembolization (TARE)
    Bommireddy, A.
    Chin, R. I.
    Malone, C.
    Kim, S. K.
    Foltz, G.
    Henke, L. E.
    Kim, H.
    Badiyan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E650 - E650
12345